Found: 10
Select item for more details and to access through your institution.
Key Opinion Leaders' Interviews to Inform the Future of Benefit–Risk Planning in the Medical Total Product Life Cycle of Global Pharmaceutical and Medical Device Organizations.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 853, doi. 10.1007/s40264-024-01442-4
- By:
- Publication type:
- Article
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 843, doi. 10.1007/s40264-024-01439-z
- By:
- Publication type:
- Article
Correction to: Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 829, doi. 10.1007/s40264-024-01444-2
- By:
- Publication type:
- Article
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000–2020.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 909, doi. 10.1007/s40264-024-01443-3
- By:
- Publication type:
- Article
Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 841, doi. 10.1007/s40264-024-01457-x
- By:
- Publication type:
- Article
Post-Conceptional Exposure to Clomiphene Citrate and Congenital Malformations: A Cohort Study.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 883, doi. 10.1007/s40264-024-01438-0
- By:
- Publication type:
- Article
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 921, doi. 10.1007/s40264-024-01437-1
- By:
- Publication type:
- Article
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 895, doi. 10.1007/s40264-024-01430-8
- By:
- Publication type:
- Article
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies.
- Published in:
- Drug Safety, 2024, v. 47, n. 9, p. 869, doi. 10.1007/s40264-024-01436-2
- By:
- Publication type:
- Article